Clinical Trials List
Protocol NumberLOXO-BTK-20022 (J2N-OX-JZNO)
2021-08-02 - 2026-09-18
Phase III
Recruiting2
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Ming-Chung Kao Division of Hematology & Oncology
- 王元欽 Division of Hematology & Oncology
- Hung Chang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- - - Division of Hematology & Oncology
- Wen-Chien Chou Division of Others -
- MING YAO Division of Hematology & Oncology
- Tai-Chung Huang Division of Hematology & Oncology
- 劉高郎 Division of Radiology
- Chieh-Lung Cheng Division of Hematology & Oncology
- HSIN-AN HOU Division of Hematology & Oncology
- Chien-Chin Lin Division of Others -
- CHENG-HONG TSAI Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- SHAN-CHI YU Division of Others -
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
600 participants
